Important Update: Our medical device testing business has joined NAMSA
On January 7, 2026, Labcorp announced the sale of our Early Development medical device testing business to NAMSA. Labcorp remains committed to completing all ongoing studies, and our clients continue to be our top priority throughout this transition.
You will be redirected to NAMSA in 20 seconds. If the redirect does not occur, click here.
